Literature DB >> 26755488

Brain MRI abnormalities in the adult form of myotonic dystrophy type 1: A longitudinal case series study.

Renata Conforti1, Mario de Cristofaro2, Adriana Cristofano3, Barbara Brogna4, Angela Sardaro4, Gioacchino Tedeschi2, Sossio Cirillo4, Alfonso Di Costanzo3.   

Abstract

This study aimed to verify whether brain abnormalities, previously described in patients with myotonic dystrophy type 1 (DM1) by magnetic resonance imaging (MRI), progressed over time and, if so, to characterize their progression. Thirteen DM1 patients, who had at least two MRI examinations, were retrospectively evaluated and included in the study. The mean duration (± standard deviation) of follow-up was 13.4 (±3.8) years, over a range of 7-20 years. White matter lesions (WMLs) were rated by semi-quantitative method, the signal intensity of white matter poster-superior to trigones (WMPST) by reference to standard images and brain atrophy by ventricular/brain ratio (VBR). At the end of MRI follow-up, the scores relative to lobar, temporal and periventricular WMLs, to WMPST signal intensity and to VBR were significantly increased compared to baseline, and MRI changes were more evident in some families than in others. No correlation was found between the MRI changes and age, onset, disease duration, muscular involvement, CTG repetition and follow-up duration. These results demonstrated that white matter involvement and brain atrophy were progressive in DM1 and suggested that progression rate varied from patient to patient, regardless of age, disease duration and genetic defect.
© The Author(s) 2016.

Entities:  

Keywords:  Brain; magnetic resonance imaging; myotonic dystrophy type 1; white matter disease

Mesh:

Year:  2016        PMID: 26755488      PMCID: PMC4978343          DOI: 10.1177/1971400915621325

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  61 in total

1.  Cerebral and muscle MRI abnormalities in myotonic dystrophy.

Authors:  Daniel T Franc; Ryan L Muetzel; Paul R Robinson; Craig P Rodriguez; Joline C Dalton; Cameron E Naughton; Bryon A Mueller; Jeffrey R Wozniak; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2012-01-30       Impact factor: 4.296

2.  The effect of repositioning error on serial magnetic resonance imaging scans.

Authors:  D E Goodkin; S Vanderburg-Medendorp; J Ross
Journal:  Arch Neurol       Date:  1993-06

3.  Somatic instability of CTG repeats in the cerebellum of myotonic dystrophy type 1.

Authors:  Kenji Jinnai; Maki Mitani; Naonobu Futamura; Kunihiko Kawamoto; Itaru Funakawa; Kyoko Itoh
Journal:  Muscle Nerve       Date:  2013-04-29       Impact factor: 3.217

4.  Anterior temporal white matter lesions in myotonic dystrophy with intellectual impairment: an MRI and neuropathological study.

Authors:  A Ogata; S Terae; M Fujita; K Tashiro
Journal:  Neuroradiology       Date:  1998-07       Impact factor: 2.804

5.  Brain MRI features of congenital- and adult-form myotonic dystrophy type 1: case-control study.

Authors:  Alfonso Di Costanzo; Francesco Di Salle; Lucio Santoro; Vincenzo Bonavita; Gioacchino Tedeschi
Journal:  Neuromuscul Disord       Date:  2002-06       Impact factor: 4.296

6.  Neuroimaging study of myotonic dystrophy. I. Magnetic resonance imaging of the brain.

Authors:  T Hashimoto; M Tayama; M Miyazaki; K Murakawa; H Kawai; H Nishitani; Y Kuroda
Journal:  Brain Dev       Date:  1995 Jan-Feb       Impact factor: 1.961

Review 7.  Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  Biochim Biophys Acta       Date:  2014-05-29

8.  Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder.

Authors:  Ashok Kumar; Sarita Agarwal; Divya Agarwal; Shubha R Phadke
Journal:  Gene       Date:  2013-04-06       Impact factor: 3.688

9.  Quantification of brain atrophy in patients with myotonic dystrophy and proximal myotonic myopathy: a controlled 3-dimensional magnetic resonance imaging study.

Authors:  Jan Kassubek; Freimut D Juengling; Stefanie Hoffmann; Angela Rosenbohm; Anja Kurt; Karin Jurkat-Rott; Peter Steinbach; Michael Wolf; Albert C Ludolph; Frank Lehmann-Horn; Holger Lerche; Yvonne G Weber
Journal:  Neurosci Lett       Date:  2003-09-11       Impact factor: 3.046

Review 10.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

View more
  12 in total

1.  RAN Translation Regulated by Muscleblind Proteins in Myotonic Dystrophy Type 2.

Authors:  Tao Zu; John D Cleary; Yuanjing Liu; Monica Bañez-Coronel; Jodi L Bubenik; Fatma Ayhan; Tetsuo Ashizawa; Guangbin Xia; H Brent Clark; Anthony T Yachnis; Maurice S Swanson; Laura P W Ranum
Journal:  Neuron       Date:  2017-09-13       Impact factor: 17.173

2.  Longitudinal study in patients with myotonic dystrophy type 1: correlation of brain MRI abnormalities with cognitive performances.

Authors:  T Cabada; J Díaz; M Iridoy; P López; I Jericó; P Lecumberri; B Remirez; R Seijas; M Gomez
Journal:  Neuroradiology       Date:  2020-11-25       Impact factor: 2.804

Review 3.  Myotonic Dystrophy Type 1 Management and Therapeutics.

Authors:  Cheryl A Smith; Laurie Gutmann
Journal:  Curr Treat Options Neurol       Date:  2016-12       Impact factor: 3.598

4.  Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1.

Authors:  Sigrid Baldanzi; Paolo Cecchi; Serena Fabbri; Ilaria Pesaresi; Costanza Simoncini; Corrado Angelini; Ubaldo Bonuccelli; Mirco Cosottini; Gabriele Siciliano
Journal:  Neuroimage Clin       Date:  2016-06-15       Impact factor: 4.881

Review 5.  Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.

Authors:  Genevieve Gourdon; Giovanni Meola
Journal:  Front Cell Neurosci       Date:  2017-04-20       Impact factor: 5.505

6.  Mbnl1 and Mbnl2 regulate brain structural integrity in mice.

Authors:  Naomi S Sta Maria; Chenyu Zhou; Se Jung Lee; Parvin Valiulahi; Xiandu Li; Jongkyu Choi; Xiaodan Liu; Russell Jacobs; Lucio Comai; Sita Reddy
Journal:  Commun Biol       Date:  2021-11-30

7.  Altered power spectral density in the resting-state sensorimotor network in patients with myotonic dystrophy type 1.

Authors:  Jin-Sung Park; Jeehye Seo; Hyunsil Cha; Hui-Jin Song; Sang-Hoon Lee; Kyung Eun Jang; Hui Joong Lee; Juyoung Park; Ho-Won Lee; Yongmin Chang
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

Review 8.  Current Progress in CNS Imaging of Myotonic Dystrophy.

Authors:  Martina Minnerop; Carla Gliem; Cornelia Kornblum
Journal:  Front Neurol       Date:  2018-08-21       Impact factor: 4.003

9.  Diffusion tensor imaging and voxel-based morphometry reveal corticospinal tract involvement in the motor dysfunction of adult-onset myotonic dystrophy type 1.

Authors:  Jin-Sung Park; Huijin Song; Kyung Eun Jang; Hyunsil Cha; Sang-Hoon Lee; Su-Keong Hwang; Donghwi Park; Hui Joong Lee; Jun-Young Kim; Yongmin Chang
Journal:  Sci Rep       Date:  2018-10-22       Impact factor: 4.379

10.  Outcome Measures for Central Nervous System Evaluation in Myotonic Dystrophy Type 1 May Be Confounded by Deficits in Motor Function or Insight.

Authors:  Mark J Hamilton; John McLean; Sarah Cumming; Bob Ballantyne; Josephine McGhie; Ravi Jampana; Cheryl Longman; Jonathan J Evans; Darren G Monckton; Maria Elena Farrugia
Journal:  Front Neurol       Date:  2018-10-02       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.